Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2 interacting protein 3 pseudogene 36 (BNIP3P36)
- Target
- BNIP3P36
- Molecular classification
- Other, Pseudogene
01
Overview
BCL2 interacting protein 3 pseudogene 36 (BNIP3P36) is a non-protein-coding pseudogene, meaning it is a segment of DNA that arose as a copy of a functional gene but is nonfunctional and does not produce a functional protein product[2][6]. Unlike the functional BNIP3 gene, which has roles in apoptosis and cancer biology, BNIP3P36 does not participate in cellular signaling or physiological regulation and is not considered a therapeutic target or meaningful in disease biology[2][6]. There is no evidence or literature supporting any role for BNIP3P36 in drug interaction, biomarker discovery, or safety concerns[2][6].
- Other names
- BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 36BNIP3P36
02
Mechanism of action
None (no drugs act on this pseudogene)
03
Biological functions
None (pseudogene; does not encode a functional protein or receptor)
04
Disease associations
None (no known role in disease due to lack of protein function)
05
Safety considerations
None (no therapeutic relevance, hence no safety concerns)
06
Interacting drugs
None (not a drug target; no direct interactions due to non-functionality)
07
Biomarkers
None (not used for patient selection or monitoring)
Beyond the preview
Go deeper on BCL2 interacting protein 3 pseudogene 36 (BNIP3P36).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 36 (BNIP3P36).